Clinical Trial Update: Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease [NA]

View source ↗

Summary

A clinical trial is evaluating fermented Protaetia Brevitarsis Seulensis powder for alcoholic liver disease, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Disease

Drugs mentioned

• Fermented Protaetia Brevitarsis Seulensis Powder

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: Alcoholic Liver Disease | NA | Status: RECRUITING